Months after developing one of the nation’s first saliva-based coronavirus tests, researchers at Rutgers University are closing in on their next breakthrough: A saliva test for both COVID-19 and the flu. The research is being conducted at RUCDR Infinite Biologics — a unit of Rutgers’ Human Genetics Institute of New Jersey — the same lab that gained federal approval in April for a coronavirus saliva test. The test allows people to collect their own samples at home and send them to be processed. Andrew Brooks, chief operating officer and director of technology development at RUCDR, said the lab hopes to have a test approved by the fall. And just in time for flu season. To read the full story.
- Rutgers Health and RWJBarnabas Health Receive Grant to Train Health Professionals and Improve Care
- Register Now for Rutgers Health Anniversary Symposium on March 20th
- New NJACTS Publication
- Study Charts Possibilities for a Better Way to Diagnose Gestational Diabetes.
- An NIH-funded R25 Summer Research/Education Program – Apply Now